New retrospective study in CHEST found procalcitonin testing at admission reduced the length of stay and total cost of care Each year, over $20 billion dollars is spent on sepsis care, making it the ...

A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) ...

A groundbreaking UK study in The Lancet has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in ...

The sixth most common principal diagnosis, sepsis, also takes the title as the most expensive inpatient diagnosis, racking up about $20 billion in hospitals’ aggregated annual costs. Sepsis isn’t ...

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with ...

Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections and sepsis. In this ...

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.

A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous ...